Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
392.54
-1.89 (-0.48%)
At close: Aug 31, 2026, 4:00 PM EDT
392.54
0.00 (0.00%)
After-hours: Aug 31, 2026, 7:30 PM EDT

Elevance Health Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
4,9635,6625,9805,9875,8946,158
Depreciation & Amortization
7107436591,0601,076817
Other Amortization
803803734685599485
Gain (Loss) on Sale of Assets
---201---
Stock-Based Compensation
244276191289264255
Change in Accounts Receivable
-260-2,526-683-1,762-2,510-2,138
Change in Accounts Payable
1,714-720-2721,640824719
Change in Unearned Revenue
79-15-113290-42-113
Change in Income Taxes
-412-297404-103-338140
Change in Insurance Reserves / Liabilities
1,057228-1,8401472,4112,523
Change in Other Net Operating Assets
-75253785-74778-8
Other Operating Activities
-373629642915
Operating Cash Flow
7,4644,2905,8088,0618,3998,364
Operating Cash Flow Growth
15.65%-26.14%-27.95%-4.02%0.42%-21.74%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1,175-1,116-1,256-1,296-1,152-1,087
Cash Acquisitions
3988-4,809-1,552-649-3,476
Investment in Securities
-1,07369586-2,700-2,338-4,056
Other Investing Activities
-34-385-51-24-421-1,019
Investing Cash Flow
-2,243-1,344-5,167-5,572-4,560-9,638

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-3,2032753392,6002,331
Long-Term Debt Issued
-2,9917,7102,5743,0713,462
Total Debt Issued
6,0646,1947,9852,9135,6715,793
Total Debt Repaid
-5,518-3,867-2,498-2,251-3,574-2,494
Net Debt Issued (Repaid)
5462,3275,4876622,0973,299
Issuance of Common Stock
12179221152182203
Repurchases of Common Stock
-2,732-2,637-3,009-2,775-2,409-2,002
Common Dividends Paid
-1,507-1,529-1,508-1,395-1,229-1,104
Other Financing Activities
4222274127
Financing Cash Flow
-3,530-1,7381,193-3,349-1,318423

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-19-5-6-1-14-10
Miscellaneous Cash Flow Adjustments
---66---
Net Cash Flow
1,6721,2031,762-8612,507-861

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
6,2893,1744,5526,7657,2477,277
Free Cash Flow Growth
17.84%-30.27%-32.71%-6.65%-0.41%-24.72%
Free Cash Flow Margin
3.13%1.59%2.57%3.95%4.63%5.25%
Free Cash Flow Per Share
28.4714.1319.5528.5029.8529.48
Levered Free Cash Flow
4,3063,4007,2623,0058,4253,614
Unlevered Free Cash Flow
5,2064,2778,0023,6498,9604,115

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1,4101,4101,2391,032878822
Cash Income Tax Paid
315315--1,5941,299
Change in Working Capital
1,426-3,277-1,719-5354231,123
SEC Filings: 10-K · 10-Q